CCL2 and Erythema: Of note, SUM149, an IBC line, which does not express CCL2 at the RNA and protein level, showed a much less aggressive IBC phenotype, lacking erythema or dermal lymphatic invasion and with significantly less inflammatory infiltrate as compared to A3250.